HCA Healthcare Inc.
HCABusiness Overview
ticker: HCA step: 01 generated: 2026-05-12 source: quick-research
HCA Healthcare, Inc. (HCA) — Business Overview
Business Description
HCA Healthcare is the largest for-profit healthcare provider in the United States — operates 190 hospitals + ~2,500 ambulatory sites of care (surgery centers, freestanding ERs, urgent care, physician clinics) in 19 states + United Kingdom. Captures ~5% of total US hospital admissions. Hub-and-spoke operating model links acute-care hospitals with outpatient centers to capture patients across the entire care continuum.
Revenue Model
~$75.6B FY2025 revenue from hospital-based services + outpatient services (now 42% of patient revenue). Payer mix FY2025: Managed Care + Private Insurance ~48%, Medicare ~32%, Medicaid ~10%, Self-Pay + International ~10%. Revenue per admission rises with patient acuity (case mix). Scale + payer-negotiation leverage = best-in-class economics among hospital systems.
Products & Services
- 190 Acute Care Hospitals — Cardiac, oncology, neurosciences, orthopedic, emergency, women's services
- ~125 Freestanding Outpatient Surgery Centers — Lower-cost surgical settings
- Freestanding ERs + Urgent Care Centers — Capture entry-point patient acquisition
- Physician Clinics — Primary + specialist physician network
- Sarah Cannon Cancer Network — Multi-state oncology platform
- HealthONE — Major Denver-area health system
- MD Now Urgent Care — Florida urgent care platform
- HCA International — UK operations (London Bridge Hospital, etc.)
Customer Base & Go-to-Market
~38M patient encounters annually. Concentrated in growth markets: Texas, Florida (largest), Tennessee, Virginia, Nevada, Colorado, Indiana. Geographic concentration in high-growth Sun Belt states + UK. Diversified payer mix protects from single-payer concentration risk.
Competitive Position
#1 US for-profit hospital operator by revenue + size. Competes with Tenet Healthcare (THC), Universal Health Services (UHS), Community Health Systems (CYH), HCA Florida vs nonprofits AdventHealth, Baptist, Memorial. Differentiation: scale + hub-and-spoke + data analytics + capital investment in growth corridors + acuity mix shift.
Key Facts
- Founded: 1968
- Headquarters: Nashville, TN
- Employees: ~280,000 (caregivers + physicians + staff)
- Exchange: NYSE (HCA)
- Sector / Industry: Healthcare / Healthcare Facilities (Hospitals)
- Market Cap: ~$110-120B
- CEO: Sam Hazen (since 2019)
Financial Snapshot
ticker: HCA step: 04 generated: 2026-05-12 source: quick-research
HCA Healthcare, Inc. (HCA) — Financial Snapshot
Income Statement Summary
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | YoY (25) |
|---|---|---|---|---|---|
| Revenue | $60.2B | $64.97B | $70.6B | $75.6B | +7.1% |
| Same-Facility Admissions Growth | -2.0% | +3.6% | +5.5% | +2.4% | |
| Adj EBITDA | $12.2B | $12.65B | $13.88B | $15.57B | +12.1% |
| EBITDA Margin | 20.3% | 19.5% | 19.7% | 20.6% | +90bps |
| Net Income | $5.64B | $5.24B | $5.76B | $6.78B | +18% |
| Diluted EPS | $19.20 | $19.65 | $22.00 | $28.33 | +29% |
FY25: Same-facility admissions +2.4% in Q4; full-year inpatient + outpatient surgery + ER visits all positive. Adj EBITDA +12%; EBITDA margin 20.6% (record high). EPS +29% (driven by share buybacks compounding effect).
Cash Flow & Balance Sheet (FY2024)
| Metric | Value |
|---|---|
| Operating Cash Flow | ~$11.5B |
| Free Cash Flow | ~$6.5B |
| Capex | ~$5.2B (record investment) |
| Cash & Equivalents | ~$1.0B |
| Total Debt | ~$42B |
| Net Debt/EBITDA | ~2.7x |
| Buybacks | $10B authorized (early 2026) |
Key Ratios (approximate)
- P/E: ~16x | EV/EBITDA: ~9-10x | FCF Yield: ~5.5%
- Revenue Growth (TTM): ~7% | Op Margin: ~15%
- Dividend Yield: ~1.0% | Modest dividend; capital return primarily via buybacks
- Aggressive buybacks: ~$8-10B annually = ~7-8% share count reduction
Growth Profile
Long-term: 5-7% revenue growth (admissions + price/acuity) + 100bps margin expansion + 10-12% adj EBITDA growth + 12-15% EPS growth (with aggressive buybacks). $5.2B capex plan adds 600-700 beds annually + ORs + ASCs. Hub-and-spoke + AI/analytics = $400M resiliency program savings.
Forward Estimates
- FY 2026: Revenue ~$80B; adj EBITDA $16-17B; adj EPS $29.10-31.50 (raised guidance)
- ACA + Medicaid headwind: $600-900M EBITDA hit (manageable)
- FY 2027: Adj EPS ~$33-36 with full-year 2026 buybacks compounding
- $10B buyback authorization (Jan 2026) for 2026-27 execution
Deeper Financial Analysis
The fundamental tier adds 9 additional research dimensions for $HCA.